Tenax Therapeutics Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20,285.7% | – | – | – | -176,351.7% | – | – | – | – | – | – | – | |
| – | 81.3% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | -2.6% | – | – | – | 56,250.0% | – | – | – | – | – | – | – | |
| – | 34,655.0% | – | – | – | 88,544.4% | – | – | – | – | – | – | – | |
| – | 27.7% | – | – | – | 0.2% | – | – | – | – | – | – | – | |
| – | -245.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -4.9% | – | – | – | – | – | – | – | |
| – | -3,013.2% | – | – | – | 3,362.3% | – | – | – | – | – | – | – | |
| – | -23,298.9% | – | – | – | -172,995.9% | – | – | – | – | – | – | – | |
| – | -20,285.7% | – | – | – | -176,351.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.